...
机译:Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA;
Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USAPeking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R ChinaHarvard Univ, Sch Med, Dept Med, Boston, MA 02115 USAHarvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USADaegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Taegu 706010, South KoreaKorea Inst Sci & Technol, Chem Kin Res Ctr, Seoul 136791, South Korea;
drug discovery; cancer drug resistance; kinase inhibitor; structure-based drug design;